FindTrial
Sign In

Schirmer test

DIAGNOSTIC_TEST5 trials

Sponsors

Belfast Health & Social Care Trust (UK), Erol Olcok Corum Training and Research Hospital, Democritus University of Thrace, IRCCS Centro Neurolesi Bonino Pulejo, University Hospital, Montpellier

Conditions

AlexithymiaDiabetic macular oedema (DMO) Eye Diseases Diabetic macular oedema (DMO)GlaucomaGlaucoma; DrugsMeibomian Gland DysfunctionOcular Surface DiseaseParkinson DiseaseRheumatoid Arthritis (RA)

Phase 2

Use of ARA 290 for the treatment of diabetic macular oedema
Active, not recruitingISRCTN16962255
Belfast Health & Social Care Trust (UK)Diabetic macular oedema (DMO) Eye Diseases Diabetic macular oedema (DMO)
Start: 2015-09-01Target: 10Updated: 2024-07-15

Unknown Phase

Effect of Eye Make up on Ocular Surface
NCT04478955
Erol Olcok Corum Training and Research HospitalMeibomian Gland Dysfunction
Start: 2020-07-01End: 2020-08-01Target: 80Updated: 2020-07-21
Ocular Surface Disease and IOP Monitoring With Travoprost Without Conservatives
CompletedNCT05319470
Democritus University of ThraceGlaucoma, Glaucoma; Drugs, Ocular Surface Disease
Start: 2022-03-15End: 2023-05-15Updated: 2023-07-05
Visuospatial and Affective Abilities in Parkinson Disease
Enrolling by invitationNCT06341829
IRCCS Centro Neurolesi Bonino PulejoAlexithymia, Parkinson Disease, Visuospatial/Perceptual Abilities
Start: 2024-04-30End: 2026-02-28Target: 126Updated: 2026-02-24
National Cohort of Subjects at Risk of Developing Rheumatoid Arthritis
Not yet recruitingNCT06876064
University Hospital, MontpellierRheumatoid Arthritis (RA)
Start: 2025-10-31End: 2027-12-31Target: 150Updated: 2025-10-01

Related Papers

A Phase 2 Clinical Trial on the Use of Cibinetide for the Treatment of Diabetic Macular Edema
Journal of Clinical Medicine2020-07-1411 citations